Biotech Ideas

[gfp927z]

Xena, Btw, on the topic of antibiotics, here's a bio stock I've been following loosely since last year (below). They have a new class of antibiotics targeting C-Difficile infections, with Phase 3 to begin in Q4. Looks interesting, and hopefully a significant improvement since it spares the broader microbiome and therefore should prevent recurrence. No position currently, but I traded it a few times in the past. The poster 'Bigworld' is a hospital pharmacist and is also following the stock -


>>> Q1 2024 Acurx Pharmaceuticals Inc Earnings Call <<<

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174464923


---